Scullion KM, MacIntyre IM, Sloan-Dennison S, Clark B, et al. Cytokeratin-18 is a sensitive biomarker of alanine transaminase increase in a placebo-controlled, randomized, crossover trial of therapeutic paracetamol dosing (PATH-BP biomarker substudy). Toxicol Sci 2024;199:203-209.
PMID: 38521541